These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

784 related items for PubMed ID: 27718216

  • 1. Predictors of Progression in IgA Nephropathy in Childhood.
    Mizerska-Wasiak M, Małdyk J, Turczyn A, Cichoń-Kawa K, Rybi-Szumińska A, Wasilewska A, Bieniaś B, Zajączkowska M, Miklaszewska M, Pietrzyk J, Demkow U, Roszkowska-Blaim M, Pańczyk-Tomaszewska M.
    Adv Exp Med Biol; 2017; 955():65-73. PubMed ID: 27718216
    [Abstract] [Full Text] [Related]

  • 2. Increased Serum IgA in Children with IgA Nephropathy, Severity of Kidney Biopsy Findings and Long-Term Outcomes.
    Mizerska-Wasiak M, Małdyk J, Pańczyk-Tomaszewska M, Turczyn A, Cichoń-Kawa K, Rybi-Szumińska A, Wasilewska A, Firszt-Adamczyk A, Stankiewicz R, Bieniaś B, Zajączkowska M, Gadomska-Prokop K, Grenda R, Miklaszewska M, Pietrzyk J, Pukajło-Marczyk, Zwolińska D, Szczepańska M, Demkow U, Roszkowska-Blaim M.
    Adv Exp Med Biol; 2015; 873():79-86. PubMed ID: 26269025
    [Abstract] [Full Text] [Related]

  • 3. Relationship between serum IgA/C3 ratio and severity of histological lesions using the Oxford classification in children with IgA nephropathy.
    Mizerska-Wasiak M, Małdyk J, Rybi-Szumińska A, Wasilewska A, Miklaszewska M, Pietrzyk J, Firszt-Adamczyk A, Stankiewicz R, Bieniaś B, Zajączkowska M, Gadomska-Prokop K, Grenda R, Pukajło-Marczyk A, Zwolińska D, Szczepańska M, Turczyn A, Roszkowska-Blaim M.
    Pediatr Nephrol; 2015 Jul; 30(7):1113-20. PubMed ID: 25549975
    [Abstract] [Full Text] [Related]

  • 4. High serum IgA/C3 ratio better predicts a diagnosis of IgA nephropathy among primary glomerular nephropathy patients with proteinuria ≤ 1 g/d: an observational cross-sectional study.
    Gong WY, Liu M, Luo D, Liu FN, Yin LH, Li YQ, Zhang J, Peng H.
    BMC Nephrol; 2019 Apr 30; 20(1):150. PubMed ID: 31039758
    [Abstract] [Full Text] [Related]

  • 5. Serum immunoglobulin A/C3 ratio predicts progression of immunoglobulin A nephropathy.
    Zhang J, Wang C, Tang Y, Peng H, Ye ZC, Li CC, Lou TQ.
    Nephrology (Carlton); 2013 Feb 30; 18(2):125-31. PubMed ID: 23134230
    [Abstract] [Full Text] [Related]

  • 6. [Influence of intensity, localization and type of deposits in renal biopsy for disease symptoms and follow up in children with IgA nephropathy].
    Cichoń-Kawa K, Mizerska-Wasiak M, Małdyk J, Turczyn A, Rybi-Szumińska A, Wasilewska A, Firszt-Adamczyk A, Stankiewicz R, Bieniaś B, Sikora P, Gadomska-Prokop K, Grenda R, Pańczyk-Tomaszewska M.
    Pol Merkur Lekarski; 2018 Apr 23; 44(262):177-182. PubMed ID: 29775444
    [Abstract] [Full Text] [Related]

  • 7. Progression of IgA nephropathy under current therapy regimen in a Chinese population.
    Li X, Liu Y, Lv J, Shi S, Liu L, Chen Y, Zhang H.
    Clin J Am Soc Nephrol; 2014 Mar 23; 9(3):484-9. PubMed ID: 24408121
    [Abstract] [Full Text] [Related]

  • 8. Combined Effects of the Serum IgA/C3 Ratio and Glomerular C3 Staining on the Renal Outcome in Adult Immunoglobulin A Nephropathy.
    Yang D, Pei G, Wang S, Qin A, Tang Y, Qin W.
    Kidney Blood Press Res; 2024 Mar 23; 49(1):246-257. PubMed ID: 38382485
    [Abstract] [Full Text] [Related]

  • 9. Treatment of IgA nephropathy.
    Pozzi C.
    J Nephrol; 2016 Feb 23; 29(1):21-5. PubMed ID: 26577268
    [Abstract] [Full Text] [Related]

  • 10. Valsartan combined with clopidogrel and/or leflunomide for the treatment of progressive immunoglobulin A nephropathy.
    Cheng G, Liu D, Margetts P, Liu L, Zhao Z, Liu Z, Tang L, Fang Y, Li H, Guo Y, Chen F, Liu F.
    Nephrology (Carlton); 2015 Feb 23; 20(2):77-84. PubMed ID: 25358874
    [Abstract] [Full Text] [Related]

  • 11. Soluble interleukin-2 receptor alfa predicts renal outcome in IgA nephropathy.
    Lundberg S, Lundahl J, Gunnarsson I, Sundelin B, Jacobson SH.
    Nephrol Dial Transplant; 2012 May 23; 27(5):1916-23. PubMed ID: 21940483
    [Abstract] [Full Text] [Related]

  • 12. Validation of some pathophysiological mechanisms of the CKD progression theory and outcome prediction in IgA nephropathy.
    Bazzi C, Rizza V, Casellato D, Stivali G, Rachele G, Napodano P, Olivieri G, Gallieni M, D'Amico G.
    J Nephrol; 2012 May 23; 25(5):810-8. PubMed ID: 22252844
    [Abstract] [Full Text] [Related]

  • 13. Prognostic factors and therapy assessment of IgA nephropathy: report from a single unit in iran.
    Soleymanian T, Najafi I, Salimi BH, Broomand B.
    Ren Fail; 2011 May 23; 33(6):572-7. PubMed ID: 21663387
    [Abstract] [Full Text] [Related]

  • 14. The effect of renin-angiotensin system blockade on the incidence of end-stage renal disease in IgA nephropathy.
    Tanaka S, Ninomiya T, Katafuchi R, Masutani K, Nagata M, Tsuchimoto A, Hirakata H, Kitazono T, Tsuruya K.
    Clin Exp Nephrol; 2016 Oct 23; 20(5):689-698. PubMed ID: 26564155
    [Abstract] [Full Text] [Related]

  • 15. IgA nephropathy clinicopathologic study following the Oxford classification: Progression peculiarities and gender-related differences.
    Riispere Ž, Laurinavičius A, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M.
    Medicina (Kaunas); 2016 Oct 23; 52(6):340-348. PubMed ID: 27932191
    [Abstract] [Full Text] [Related]

  • 16. Clinical and histopathologic profile of patients with primary IgA nephropathy seen in a tertiary hospital in India.
    Bagchi S, Singh G, Yadav R, Kalaivani M, Mahajan S, Bhowmik D, Dinda A, Agarwal SK.
    Ren Fail; 2016 Oct 23; 38(3):431-6. PubMed ID: 26837482
    [Abstract] [Full Text] [Related]

  • 17. Mesangial C3 deposition and serum C3 levels predict renal outcome in IgA nephropathy.
    Wu D, Li X, Yao X, Zhang N, Lei L, Zhang H, Tang M, Ni J, Ling C, Chen Z, Chen X, Liu X.
    Clin Exp Nephrol; 2021 Jun 23; 25(6):641-651. PubMed ID: 33620604
    [Abstract] [Full Text] [Related]

  • 18. Serum IgA/C3 ratio and glomerular C3 staining predict progression of IgA nephropathy in children.
    Lang Y, Song S, Zhao L, Yang Y, Liu T, Shen Y, Wang W.
    Transl Pediatr; 2021 Mar 23; 10(3):666-672. PubMed ID: 33880336
    [Abstract] [Full Text] [Related]

  • 19. Significance of clinical and morphological prognostic risk factors in IgA nephropathy: follow-up study of comparison patient groups with and without renoprotection.
    Riispere Ž, Kuudeberg A, Seppet E, Sepp K, Ilmoja M, Luman M, Kõlvald K, Auerbach A, Ots-Rosenberg M.
    BMC Nephrol; 2017 Mar 14; 18(1):89. PubMed ID: 28292274
    [Abstract] [Full Text] [Related]

  • 20. Risk factors for progression in children and young adults with IgA nephropathy: an analysis of 261 cases from the VALIGA European cohort.
    Coppo R, Lofaro D, Camilla RR, Bellur S, Cattran D, Cook HT, Roberts IS, Peruzzi L, Amore A, Emma F, Fuiano L, Berg U, Topaloglu R, Bilginer Y, Gesualdo L, Polci R, Mizerska-Wasiak M, Caliskan Y, Lundberg S, Cancarini G, Geddes C, Wetzels J, Wiecek A, Durlik M, Cusinato S, Rollino C, Maggio M, Praga M, K Smerud H, Tesar V, Maixnerova D, Barratt J, Papalia T, Bonofiglio R, Mazzucco G, Giannakakis C, Soderberg M, Orhan D, Di Palma AM, Maldyk J, Ozluk Y, Sudelin B, Tardanico R, Kipgen D, Steenbergen E, Karkoszka H, Perkowska-Ptasinska A, Ferrario F, Gutierrez E, Honsova E.
    Pediatr Nephrol; 2017 Jan 14; 32(1):139-150. PubMed ID: 27557557
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 40.